Aisling Capital as of Dec. 31, 2017
Portfolio Holdings for Aisling Capital
Aisling Capital holds 12 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Loxo Oncology | 57.2 | $290M | 3.4M | 84.18 | |
| Aimmune Therapeutics | 16.7 | $85M | 2.2M | 37.82 | |
| Viewray (VRAYQ) | 13.7 | $69M | 7.5M | 9.26 | |
| Transenterix | 3.8 | $19M | 9.9M | 1.93 | |
| Entellus Medical Cm | 2.5 | $13M | 529k | 24.39 | |
| Adma Biologics (ADMA) | 2.3 | $12M | 3.6M | 3.21 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 1.4 | $6.9M | 1.0M | 6.80 | |
| Syros Pharmaceuticals | 1.0 | $4.9M | 509k | 9.73 | |
| Agile Therapeutics | 0.7 | $3.5M | 1.3M | 2.69 | |
| Chimerix (CMRX) | 0.4 | $2.2M | 473k | 4.63 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.2 | $1.1M | 2.5M | 0.42 | |
| Pernix Therapeutics Holdings | 0.1 | $504k | 210k | 2.40 |
